In the BioHarmony Drug Report Database

"Preview" Icon

[FDA 2020 Drug Approvals]

Includes access to the collection of FDA 2020 Novel Drug Approval, including all current and future drug reports in the set (within a given subscription period).

The [FDA 2020 Novel Drug Approval] data set contains over 40 drug reports.

One example of an included drug report data is shown below for Ayvakyt.

 

Trade Name

 

Ayvakyt
 

Common Name

 

avapritinib
 

ChEMBL ID

 

CHEMBL4204794
 

Indication

 

gastrointestinal stromal tumors
 

Drug Class

 

Tyrosine kinase inhibitors

Image (chem structure or protein)

Avapritinib structure rendering